All Type of News
Number of Instances on Adverse Drug Reactions Significantly Increases
The number of instances on the adverse drug reactions that were reported during last year shows a significant year-over-year increase at about 2.5 times higher, from 393 instances in Year 2003 to 907 instances in Year...
Hanmi Makes Efforts to Boost Sluggish OTC Sales at Retail Pharmacies
Hanmi Pharmaceutical is engaging an active promotion of its over-the-counter (OTC) pharmaceutical products at the retail pharmacies, by making arrangements to supply specific OTC product showcases termed as H-POP (Han...
Average Product Lifecycles Analyzed Between Two Major Pharmaceutical Markets
The pharmaceutical industry analysis conducted by a research institute in Japan shows a product lifecycle comparison between the top ten revenue-generating products by the major local firms in the Japan market, and th...
Pfizer Korea Announces Financial Results for Year 2004
Pfizer Korea recently announced of its Year 2004 company financial results, generating a total sales revenue of 257.7 billion won which is up 5.4% from the prior fiscal period.
The company's operating profit is 43....
New Chairman of KPMA Stresses on R&D Investments and Activities
The newly appointed Chairman Huh Il-sup of the Korea Pharmaceutical Manufacturers Association (KPMA) expressed in the interview held last week that, under his new leadership, KPMA will continue to focus on promoting a...
KFDA Delays Decision on Hanmi’s Anti-Obesity Drug with Novel Salt Formulation
The delayed decision by the Korea Food and Drug Administration (KFDA) on an approval of Hanmi Pharmaceutical’s anti-obesity drug Slimer is triggering debates on the current regulatory process that governs the approval...
CKD Bio Obtains European CoS Accreditation for Antibiotic Raw Material
CKD Bio Corp., an affiliate of Chong Kun Dang Group specialized in the manufacture of pharmaceutical raw materials, announced that the company has successfully obtained a CoS (Certificate of Suitability) accreditation...
Additional Contraindications Released for Simultaneous, Age-Specific Drug Administrations
The Ministry of Health and Welfare (MOHW) recently released an addendum list of pharmaceutical contraindications that prohibit a simultaneous administration of medications containing certain active ingredients.
The...
Lilly Korea Plans to Launch Zyprexa IntraMuscular
Lilly Korea recently announced that it plans to introduce Zyprexa IntraMuscular (olanzapine for injection) in the domestic market during the first half of this year, giving the healthcare professionals a new option fo...
KFDA Revises Labeling Standards on Food Products
The Korea Food and Drug Administration (KFDA) has recently revised the labeling standards on the food products, in an effort to enable the domestic consumers to make proper and rational choices in their selections on ...
